CenExel Collaborative Neuroscience Research, LLC Los Alamitos

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials

Phase

• Phase 13 trials

Status

• Completed3 trials

Lead sponsor

• Amgen3 trials

Closed trials

• Completed

  A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations

  NCT07313761· Phase 1· Amgen· Source

• Completed

  A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity

  NCT07310563· Phase 1· Amgen· Source

• Completed

  A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity

  NCT06976372· Phase 1· Amgen· Source